RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.31
+0.96 (13.06%)
At close: Aug 13, 2025, 4:00 PM
8.03
-0.28 (-3.37%)
Pre-market: Aug 14, 2025, 9:02 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $340.01 million as of August 14, 2025. Its market cap has decreased by -80.50% in one year.
Market Cap
340.01M
Enterprise Value
124.24M
1-Year Change
-80.50%
Ranking
Category
Stock Price
$8.31
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $340.01M, a decrease of -19.87%. That is a compound annual growth rate of -5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 340.01M | -75.46% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.28B |
| Johnson & Johnson | 419.32B |
| AbbVie | 349.43B |
| Abbott Laboratories | 229.77B |
| UnitedHealth Group | 229.42B |
| Novartis AG | 228.69B |
| AstraZeneca | 227.85B |
| Novo Nordisk | 222.88B |